BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38174568)

  • 21. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
    Chen HS; Cui Y; Zhou ZH; Zhang H; Wang LX; Wang WZ; Shen LY; Guo LY; Wang EQ; Wang RX; Han J; Dong YL; Li J; Lin YZ; Yang QC; Zhang L; Li JY; Wang J; Xia L; Ma GB; Lu J; Jiang CH; Huang SM; Wan LS; Piao XY; Li Z; Li YS; Yang KH; Wang DL; Nguyen TN;
    JAMA; 2023 Jun; 329(24):2135-2144. PubMed ID: 37367978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenecteplase Thrombolysis for Acute Ischemic Stroke.
    Warach SJ; Dula AN; Milling TJ
    Stroke; 2020 Nov; 51(11):3440-3451. PubMed ID: 33045929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions: Systematic Review and Meta-Analysis.
    Katsanos AH; Safouris A; Sarraj A; Magoufis G; Leker RR; Khatri P; Cordonnier C; Leys D; Shoamanesh A; Ahmed N; Alexandrov AV; Tsivgoulis G
    Stroke; 2021 Jan; 52(1):308-312. PubMed ID: 33272127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.
    Huang X; MacIsaac R; Thompson JL; Levin B; Buchsbaum R; Haley EC; Levi C; Campbell B; Bladin C; Parsons M; Muir KW
    Int J Stroke; 2016 Jul; 11(5):534-43. PubMed ID: 27048693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke.
    Walton MN; Hamilton LA; Salyer S; Wiseman BF; Forster AM; Rowe AS
    Ann Pharmacother; 2023 May; 57(5):535-543. PubMed ID: 36004394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of tenecteplase in comparison to alteplase in acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Salamatullah HK; Bashrahil B; Alghamdi AM; Alsharm FS; Alkulli OA; Alzahrani Z; Alkhiri A; Alghamdi S; Makkawi S
    Clin Neurol Neurosurg; 2023 Oct; 233():107961. PubMed ID: 37713743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tenecteplase Versus Alteplase for Acute Stroke: Mortality and Bleeding Complications.
    Murphy LR; Hill TP; Paul K; Talbott M; Golovko G; Shaltoni H; Jehle D
    Ann Emerg Med; 2023 Dec; 82(6):720-728. PubMed ID: 37178103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Occlusion Site on the Safety and Efficacy of Intravenous Alteplase Before Endovascular Thrombectomy: A Prespecified Subgroup Analysis of DIRECT-MT.
    Zhou Y; Xing P; Li Z; Zhang X; Zhang L; Zhang Y; Zhang Y; Hong B; Xu Y; Huang Q; Li Q; Zhao K; Zou C; Yu Y; Zuo Q; Liu S; Zhang L; Majoie CBLM; Roos YBWEM; Treurniet KM; Ye X; Peng Y; Yang P; Liu J;
    Stroke; 2022 Jan; 53(1):7-16. PubMed ID: 34915738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Recanalization Among Patients Undergoing Bridging Therapy With Tenecteplase or Alteplase.
    Checkouri T; Gerschenfeld G; Seners P; Yger M; Ben Hassen W; Chausson N; Olindo S; Caroff J; Marnat G; Clarençon F; Baron JC; Turc G; Alamowitch S;
    Stroke; 2023 Oct; 54(10):2491-2499. PubMed ID: 37622385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex differences in the Norwegian Tenecteplase Trial (NOR-TEST).
    Ihle-Hansen H; Sandset EC; Ihle-Hansen H; Hagberg G; Thommessen B; Rønning OM; Kvistad CE; Novotny V; Naess H; Waje-Andreassen U; Thomassen L; Logallo N
    Eur J Neurol; 2022 Feb; 29(2):609-614. PubMed ID: 34564893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical Trial.
    Renú A; Millán M; San Román L; Blasco J; Martí-Fàbregas J; Terceño M; Amaro S; Serena J; Urra X; Laredo C; Barranco R; Camps-Renom P; Zarco F; Oleaga L; Cardona P; Castaño C; Macho J; Cuadrado-Godía E; Vivas E; López-Rueda A; Guimaraens L; Ramos-Pachón A; Roquer J; Muchada M; Tomasello A; Dávalos A; Torres F; Chamorro Á;
    JAMA; 2022 Mar; 327(9):826-835. PubMed ID: 35143603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study.
    Teivane A; Jurjāns K; Vētra J; Grigorjeva J; Kupcs K; Masiliūnas R; Miglāne E
    Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143846
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment.
    Ospel JM; Menon BK; Demchuk AM; Almekhlafi MA; Kashani N; Mayank A; Fainardi E; Rubiera M; Khaw A; Shankar JJ; Dowlatshahi D; Puig J; Sohn SI; Ahn SH; Poppe A; Calleja A; Hill MD; Goyal M
    Stroke; 2020 Nov; 51(11):3232-3240. PubMed ID: 33070714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Rose D; Cavalier A; Kam W; Cantrell S; Lusk J; Schrag M; Yaghi S; Stretz C; de Havenon A; Saldanha IJ; Wu TY; Ranta A; Barber PA; Marriott E; Feng W; Kosinski AS; Laskowitz D; Poli S; Mac Grory B
    Stroke; 2023 May; 54(5):1192-1204. PubMed ID: 36951049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial.
    Roaldsen MB; Eltoft A; Wilsgaard T; Christensen H; Engelter ST; Indredavik B; Jatužis D; Karelis G; Kõrv J; Lundström E; Petersson J; Putaala J; Søyland MH; Tveiten A; Bivard A; Johnsen SH; Mazya MV; Werring DJ; Wu TY; De Marchis GM; Robinson TG; Mathiesen EB;
    Lancet Neurol; 2023 Feb; 22(2):117-126. PubMed ID: 36549308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes and safety profile of Tenecteplase in wake-up stroke.
    Ahmed HK; Logallo N; Thomassen L; Novotny V; Mathisen SM; Kurz MW
    Acta Neurol Scand; 2020 Nov; 142(5):475-479. PubMed ID: 32511749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes with IV tenecteplase and IV alteplase for acute ischemic stroke with or without thrombectomy in real-world settings in the United States.
    Qureshi AI; Baskett WI; Bains NK; French BR; Siddiq F; Gomez CR; Shyu CR
    J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106898. PubMed ID: 36493706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial.
    Suzuki K; Matsumaru Y; Takeuchi M; Morimoto M; Kanazawa R; Takayama Y; Kamiya Y; Shigeta K; Okubo S; Hayakawa M; Ishii N; Koguchi Y; Takigawa T; Inoue M; Naito H; Ota T; Hirano T; Kato N; Ueda T; Iguchi Y; Akaji K; Tsuruta W; Miki K; Fujimoto S; Higashida T; Iwasaki M; Aoki J; Nishiyama Y; Otsuka T; Kimura K;
    JAMA; 2021 Jan; 325(3):244-253. PubMed ID: 33464334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study.
    Campbell BC; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Yan B; Thijs V; Desmond PM; Parsons MW; Donnan GA; Davis SM
    Int J Stroke; 2020 Jul; 15(5):567-572. PubMed ID: 31564231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.